Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

Development Status

Other

7

Possibly Marketed Outside US

3

All Match

Any Match

Exclude Selected

Exclude Selected

Approval Year

Unknown

8

1956

1

1995

1

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Class

Concept

7

Structurally Diverse

2

Mixture

1

All Match

Any Match

Exclude Selected

Exclude Selected

Code System

WHO-ESSENTIAL MEDICINES LIST

10

EVMPD

9

WIKIPEDIA

7

ChEMBL

6

DRUG BANK

6

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 1

ANTIINFECTIVES FOR SYSTEMIC USE

2

ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 2

VACCINES

2

IMMUNOSTIMULANTS

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 3

BACTERIAL VACCINES

2

IMMUNOSTIMULANTS

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 4

Cholera vaccines

2

Other immunostimulants

1

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Form

Principal Form

3

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for "WHO ESSENTIAL MEDICINES LIST|Immunologicals" in comments (approximate match)

Showing 1 - 10 of 10 results

First page disabled
Previous page disabled
1
Next page disabled
Next page disabled

BACILLUS CALMETTE-GUERIN LIVE ANTIGEN, UNSPECIFIED SUBSTRAIN

8VJE55B0VG

Status:

US Approved Rx (1989)

First approved in 1989

Class:

MIXTURE

HUMAN RHO(D) IMMUNE GLOBULIN

48W7181FLP

Status:

US Approved Rx (1998)

First approved in 1971

Class:

STRUCTURALLY DIVERSE

TUBERCULIN PURIFIED PROTEIN DERIVATIVE

I7L8FKN87J

Status:

US Approved Rx (2000)

First approved in 1956

Class:

STRUCTURALLY DIVERSE

CHOLERA VACCINE

V9G528E9E0

Status:

Other

Class:

CONCEPT

TYPHOID VACCINE

760T5R8B3O

Status:

Other

Class:

CONCEPT

MUMPS VACCINE

47QB6MX9KU

Status:

Other

Class:

CONCEPT

PERTUSSIS VACCINE

2QNL82089R

Status:

Other

Class:

CONCEPT

YELLOW FEVER VACCINE

PY4EET359T

Status:

Other

Class:

CONCEPT

HEPATITIS B VIRUS VACCINE

IFJ010MNE4

Status:

Other

Class:

CONCEPT

RABIES VACCINE

C6547J35OD

Status:

Other

Class:

CONCEPT

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1